The iQ Group Global secures worldwide license for Harvard University’s eRapid technology for at-home diagnostic testing 

Antisoma Therapeutics Pty Ltd., a medical technology company and member of The iQ Group Global, today announced it has received a worldwide license from Harvard’s Office of Technology Development to commercialise diagnostic technology developed at the Wyss Institute for Biologically Inspired Engineering at Harvard University, with exclusivity in the fields of respiratory viral illnesses, cancer, […]

Read More →

FDA Breakthrough Devices Designation application to fast-track painful finger-prick alternative for people living with diabetes

Market Announcement – The iQ Group Global Ltd The iQ Group Global Ltd (iQG Ltd) (NSX:IQG) on behalf of Life Science Biosensor Diagnostics Pty Ltd (LSBD), a life sciences and medical technology company, in which IQG Ltd holds 81% equity position, today announced it has filed an application with the U.S Food and Drug Administration […]

Read More →

New GM overseeing Farmaforce New Zealand expansion

Farmaforce appoints a new General Manager to expand its award-winning healthcare operations into New Zealand. With more than 20 years’ experience in the consumer health sector, founding member of Farmaforce, Natalie Urner, has been appointed its new General Manager. Committed to continuing to bolster the three-time award-winning sales force organisation’s reach in Australia, Natalie’s next […]

Read More →

GBS Awarded $6.3 million Federal Government Science Grant to Manufacture Biosensor Technology

The iQ Group Global Ltd (NSX.IQG), on behalf of its portfolio company, GBS (Nasdaq: GBS), a life sciences company developing non-invasive, real-time diagnostic testing for patients and their primary health practitioners at point-of-care, today announced it has been awarded a AUD $6.3 million, Australian Federal Government scientific grant to create a pilot Biosensor manufacturing facility. […]

Read More →